Lund, Sweden

Karin Bergling

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Gambro Lundia Ab. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Karin Bergling. Retrieved from https://idiyas.com/inventor/karin-bergling

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Karin Bergling: Inventor in Peritoneal Dialysis Assessment.

Introduction

Karin Bergling is an inventor associated with Lund, Sweden, and Gambro Lundia AB. Her patent work addresses methods for assessing the status of individuals undergoing peritoneal dialysis.

Latest Patents

Bergling is associated with 1 patent, titled “Status Assessment of an Individual Undergoing Peritoneal Dialysis.” The invention describes a test method for determining one or more status parameters, such as peritoneal transport properties, tonicity, or residual volume. It uses treatment-fluid flow-rate data and measured solute concentrations collected during a test procedure. A transport model estimates solute concentrations, which are compared with the measured samples to determine the relevant status parameter.

Career Highlights

Bergling’s documented patent contribution focuses on applying transport modeling and measured treatment-fluid data to peritoneal dialysis assessment. The patent identifies Gambro Lundia AB as her company affiliation.

Collaborations

The provided information names Per-Olof Borgqvist and Carl Öberg as Bergling’s coworkers. Their specific roles in the patent or related work are not stated.

Conclusion

Karin Bergling’s recorded invention concerns a data-driven method for assessing key clinical parameters during peritoneal dialysis, reflecting her association with Gambro Lundia AB and medical technology innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…